Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb;95(2):714-21.
doi: 10.1210/jc.2009-1879. Epub 2009 Dec 4.

Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene

Affiliations

Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene

Manuel H Aguiar-Oliveira et al. J Clin Endocrinol Metab. 2010 Feb.

Abstract

Context: Reduced longevity observed in hypopituitarism has been attributed to GH deficiency (GHD). It is, however, unclear whether GHD or other confounding factors cause this early mortality.

Objective: The aim was to study longevity in subjects from a large kindred with untreated, lifetime isolated GHD (IGHD) due to a homozygous mutation in the GHRH receptor gene and in heterozygous carriers of the mutation.

Design, setting, and participants: We carried out a retrospective cohort study on three groups. We first compared mortality risk of 65 IGHD individuals and their 128 unaffected siblings from 34 families. We then compared mean age of death of the IGHD to the general population. A transversal study was carried out to compare the rate of heterozygosity for the mutation in two groups of young (20-40 yr old) and old (60-80 yr old) normal-appearing subjects from the same county.

Main outcome measure: We measured longevity.

Results: The risk of death of IGHD subjects was not different from their siblings. Life span in IGHD individuals was shorter than the general population. When stratified by sex, this difference persisted only in females, due to a high frequency of IGHD deaths in females aged 4-20. There was no significant difference in life span between IGHD subjects and siblings or the general population when analyzing subjects who reached age 20. The prevalence of heterozygosity did not differ in young and old groups, suggesting no survival advantage or disadvantage.

Conclusions: In a selected genetic background, lifelong untreated IGHD does not affect longevity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan-Meier survival curves. Solid lines, IGHD subjects; dotted lines, unaffected siblings. A and B, Both sexes; C and D, males; E and F, females. A, C, and E, Individuals of all ages; B, D, and F, individuals who reached age 20. Values under each graph are the numbers at risk by group.

Similar articles

Cited by

References

    1. vB Hjelmborg J, Iachine I, Skytthe A, Vaupel JW, McGue M, Koskenvuo M, Kaprio J, Pedersen NL, Christensen K 2006 Genetic influence on human longevity. Hum Genet 119:312–321 - PubMed
    1. Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R 1993 A C. elegans mutant that lives twice as long as wild-type. Nature 366:461–464 - PubMed
    1. Fabrizio P, Pozza F, Pletcher SD, Gendron CM, Longo VD 2001 Regulation of longevity and stress resistance by Sch9 in yeast. Science 292:288–290 - PubMed
    1. Tatar M, Kopelman A, Epstein D, Tu MP, Yin CM, Garofalo RS 2001 A mutant Drosophila insulin receptor homologue that extends life span and impairs neuroendocrine function. Science 292:107–110 - PubMed
    1. Bartke A 2009 The somatotropic axis and aging: mechanisms and persistent questions about practical implications. Exp Gerontol 44:372–374 - PMC - PubMed

Publication types

Substances